As the Australian share market edges towards a soft upswing, buoyed by global political developments and commodity price movements, investors are keenly observing potential opportunities. Penny stocks, though often seen as a term from past market eras, continue to hold relevance for those looking to explore beyond established names. These smaller or newer companies can offer affordability and growth potential when backed by robust financials; in this article, we highlight three such penny stocks that stand out for their financial resilience and promising prospects. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.475 A$136.13M ★★★★★☆ Dusk Group (ASX:DSK) A$0.90 A$56.04M ★★★★★★ IVE Group (ASX:IGL) A$2.76 A$424.49M ★★★★★☆ MotorCycle Holdings (ASX:MTO) A$3.42 A$252.42M ★★★★★★ Pureprofile (ASX:PPL) A$0.043 A$50.3M ★★★★★★ West African Resources (ASX:WAF) A$3.04 A$3.47B ★★★★★★ LaserBond (ASX:LBL) A$0.505 A$59.63M ★★★★★★ Fleetwood (ASX:FWD) A$3.17 A$292.7M ★★★★★★ GWA Group (ASX:GWA) A$2.48 A$652.07M ★★★★★☆ Clover (ASX:CLV) A$0.625 A$104.37M ★★★★★★ Click here to see the full list of 419 stocks from our ASX Penny Stocks screener. Let's uncover some gems from our specialized screener. Alfabs Australia Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Alfabs Australia Limited operates in the mining equipment and engineering sector within Australia, with a market cap of A$136.13 million. Operations: The company generates revenue through its Mining segment, which contributes A$45.40 million, and its Engineering segment, which accounts for A$46.34 million. Market Cap: A$136.13M Alfabs Australia Limited, with a market cap of A$136.13 million, operates in the mining equipment and engineering sector. It reported sales of A$95.5 million for the year ending June 30, 2025, with net income rising to A$12.17 million from A$3.55 million the previous year. Although its Return on Equity is low at 18.8%, earnings grew by a very large margin over the past year compared to industry averages and are forecasted to grow further by 12.23% annually. The company's debt is well covered by operating cash flow, but its dividend sustainability remains questionable due to insufficient free cash flows. Click to explore a detailed breakdown of our findings in Alfabs Australia's financial health report. Explore Alfabs Australia's analyst forecasts in our growth report.ASX:AAL Debt to Equity History and Analysis as at Oct 2025 Bubs Australia Simply Wall St Financial Health Rating: ★★★★★★ Overview: Bubs Australia Limited, with a market cap of A$138.59 million, manufactures and sells infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally. Story Continues Operations: The company generates revenue primarily from its food processing segment, amounting to A$102.54 million. Market Cap: A$138.59M Bubs Australia, with a market cap of A$138.59 million, has recently transitioned to profitability, reporting A$5.54 million in net income for the year ending June 30, 2025. Despite low Return on Equity at 13.1%, its revenue reached A$102.54 million, marking significant growth from the previous year. The company is debt-free and has stable weekly volatility at 9%. However, concerns about its long-term viability have been raised by auditors expressing doubts over its going concern status. Recent leadership changes include the appointment of Joe Coote as CEO and Ms Olga Smejkalova as Company Secretary. Take a closer look at Bubs Australia's potential here in our financial health report. Understand Bubs Australia's earnings outlook by examining our growth report.ASX:BUB Financial Position Analysis as at Oct 2025 Parkway Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Parkway Corporate Limited, with a market cap of A$35.97 million, provides water treatment products and solutions in Australia. Operations: The company generates revenue of A$15.12 million from its water treatment related products and services segment. Market Cap: A$35.97M Parkway Corporate Limited, with a market cap of A$35.97 million, has shown promising growth by becoming profitable this year, reporting sales of A$15.14 million for the full year ending June 30, 2025. The company holds more cash than debt and its operating cash flow comfortably covers its liabilities. While Parkway's Return on Equity remains low at 0.1%, it has secured contracts worth over A$13.50 million in water infrastructure projects, expecting additional revenue recognition in fiscal year 2026 despite potential delays in project timelines. The board and management are experienced with stable weekly volatility at 13%. Unlock comprehensive insights into our analysis of Parkway stock in this financial health report. Review our historical performance report to gain insights into Parkway's track record.ASX:PWN Debt to Equity History and Analysis as at Oct 2025 Where To Now? Dive into all 419 of the ASX Penny Stocks we have identified here. Searching for a Fresh Perspective? The latest GPUs need a type of rare earth metal called Dysprosium and there are only 37 companies in the world exploring or producing it. Find the list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:AAL ASX:BUB and ASX:PWN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX Penny Stocks With Market Caps Over A$30M To Watch
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...